Gene · 8740
Papers1,880
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
581 to 600 of 1,880
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The soluble VCAM-1 level is a potential biomarker predicting severe acute graft versus host disease after allogeneic hematopoietic cell transplantation. | BMC Cancer | 2022 | 36127634 | PubTator, text mining | PubMed |
| Tofacitinib treatment modulates the levels of several inflammation-related plasma proteins in rheumatoid arthritis and baseline levels of soluble biomarkers associate with the treatment response. | Clin Exp Immunol | 2022 | 36124688 | PubTator, text mining | PubMed |
| SLC22A8: An indicator for tumor immune microenvironment and prognosis of ccRCC from a comprehensive analysis of bioinformatics. | Medicine (Baltimore) | 2022 | 36123895 | PubTator, text mining | PubMed |
| Mutated processes predict immune checkpoint inhibitor therapy benefit in metastatic melanoma. | Nat Commun | 2022 | 36123351 | PubTator, text mining | PubMed |
| Genetic and immunologic evaluation of children with inborn errors of immunity and severe or critical COVID-19. | J Allergy Clin Immunol | 2022 | 36113674 | PubTator, text mining | PubMed |
| O-Glycosylating Enzyme GALNT2 Predicts Worse Prognosis in Cervical Cancer. | Pathol Oncol Res | 2022 | 36110252 | PubTator, text mining | PubMed |
| Subtype Classification and Prognosis Signature Construction of Osteosarcoma Based on Cellular Senescence-Related Genes. | J Oncol | 2022 | 36106335 | PubTator, text mining | PubMed |
| CDK2AP1 influences immune infiltrates and serves as a prognostic indicator for hepatocellular carcinoma. | Front Genet | 2022 | 36105112 | PubTator, text mining | PubMed |
| Identification of hub genes related to CD4+ memory T cell infiltration with gene co-expression network predicts prognosis and immunotherapy effect in colon adenocarcinoma. | Front Genet | 2022 | 36105107 | PubTator, text mining | PubMed |
| Identification and validation of a novel cellular senescence-related lncRNA prognostic signature for predicting immunotherapy response in stomach adenocarcinoma. | Front Genet | 2022 | 36092903 | PubTator, text mining | PubMed |
| Development and validation of a novel endoplasmic reticulum stress-related lncRNA prognostic signature and candidate drugs in breast cancer. | Front Genet | 2022 | 36092873 | PubTator, text mining | PubMed |
Machine learning-based screening of an epithelial-mesenchymal transition-related long non-coding RNA signature reveals lower-grade glioma prognosis and the tumor microenvironment and predicts antitumor therapy response. | Front Mol Biosci | 2022 | 36090045 | PubTator, text mining | PubMed |
| Association of the inflammation-related proteome with dementia development at older age: results from a large, prospective, population-based cohort study. | Alzheimers Res Ther | 2022 | 36085081 | PubTator, text mining | PubMed |
| An integrative analysis revealing POLD2 as a tumor suppressive immune protein and prognostic biomarker in pan-cancer. | Front Genet | 2022 | 36081989 | PubTator, text mining | PubMed |
| A Genomic Instability-Related Long Noncoding RNA Signature for Predicting Hepatocellular Carcinoma Prognosis. | J Oncol | 2022 | 36072979 | PubTator, text mining | PubMed |
| Development and validation of a novel fibroblast scoring model for lung adenocarcinoma. | Front Oncol | 2022 | 36072807 | PubTator, text mining | PubMed |
| Global and local ancestry modulate APOE association with Alzheimer's neuropathology and cognitive outcomes in an admixed sample. | Mol Psychiatry | 2022 | 36071110 | PubTator, text mining | PubMed |
| Beyond the vaccines: a glance at the small molecule and peptide-based anti-COVID19 arsenal. | J Biomed Sci | 2022 | 36064696 | PubTator, text mining | PubMed |
| Identification of a prognostic model based on costimulatory molecule-related subtypes and characterization of tumor microenvironment infiltration in acute myeloid leukemia. | Front Genet | 2022 | 36061194 | PubTator, text mining | PubMed |
| Comprehensive analysis of the prognostic and immunotherapeutic implications of STAT family members in human colorectal cancer. | Front Genet | 2022 | 36061181 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8740/papers?page=30